Compare ILMN & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | DECK |
|---|---|---|
| Founded | 1998 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0B | 12.4B |
| IPO Year | 2000 | 1996 |
| Metric | ILMN | DECK |
|---|---|---|
| Price | $295.05 | $79.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 27 |
| Target Price | ★ $214.60 | $120.41 |
| AVG Volume (30 Days) | 2.5M | ★ 2.9M |
| Earning Date | 10-29-2026 | 10-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 170.87 | 10.90 |
| EPS | ★ 2.22 | 0.94 |
| Revenue | $4,343,000,000.00 | ★ $5,472,296,000.00 |
| Revenue This Year | $6.47 | $7.43 |
| Revenue Next Year | $6.40 | $7.23 |
| P/E Ratio | $132.60 | ★ $84.99 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $88.00 | $77.37 |
| 52 Week High | $296.25 | $122.29 |
| Indicator | ILMN | DECK |
|---|---|---|
| Relative Strength Index (RSI) | 77.17 | 42.29 |
| Support Level | $118.76 | $77.37 |
| Resistance Level | N/A | $83.00 |
| Average True Range (ATR) | 13.83 | 2.02 |
| MACD | 3.75 | 0.64 |
| Stochastic Oscillator | 99.71 | 44.90 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.